[The approaches of chronic graft-versus-host disease].
Chronic graft-versus-host disease (cGVHD) continues to be a major complication in long-term survivors after allogeneic hematopoietic stem cell transplantation and is the principal cause of morbidity and non-relapse mortality. With the new approaches in the immune mechanisms of cGVHD, the diagnosis, prophylaxis and treatment of cGVHD are involved. This review summarises the current progress of research on cGVHD.
Wang
Shu-Hong
SH
Department of Hematology, The General Hospital of PLA, Beijing 100853, China.
Da
Wan-Ming
WM
D002908:Chronic Disease; D005260:Female; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D008297:Male; D011379:Prognosis; D012307:Risk Factors